Jan 02, 2018 21:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 02, 2018 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced that on...
LPL Financial Announces Fourth Quarter and Full Year 2017 Earnings Release Date and Conference Call
Jan 02, 2018 21:05 pm UTC| Business
SAN DIEGO, Jan. 02, 2018 -- Leading retail investment advisory firm and independent broker/dealer LPL Financial LLC, a wholly owned subsidiary of LPL Financial Holdings Inc. (NASDAQ:LPLA) (collectively, the “Company”),...
Update on progress in cystic fibrosis programs
Jan 02, 2018 21:02 pm UTC| Business
Positive results with FLAMINGO study C1 corrector GLPG2222 as monotherapy in homozygous Class II F508del CF patients Study over-recruited within 5 months in the US and Europe GLPG2222 was well tolerated when dosed...
Atara Biotherapeutics Announces Proposed Offering of Common Stock
Jan 02, 2018 21:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 02, 2018 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral...
Lexicon Pharmaceuticals Announces Poster Presentation at ASCO GI
Jan 02, 2018 21:01 pm UTC| Business
THE WOODLANDS, Texas, Jan. 02, 2018 -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), announced today that data from a poster highlighting XERMELO® (telotristat ethyl) will be presented at the upcoming 2018 American...
Jan 02, 2018 21:01 pm UTC| Business
CHESTERBROOK, Pa., Jan. 02, 2018 -- Trevena, Inc. (NASDAQ:TRVN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for OLINVO™ (oliceridine)...
pSivida to Present at the Annual Biotech Showcase Conference
Jan 02, 2018 21:01 pm UTC| Business
WATERTOWN, Mass., Jan. 02, 2018 -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products, announced today that Nancy Lurker, President and Chief Executive...